GPRIN2 and neoplasm: In that study, we found that miR-490-3p acted as a tumor-suppressive miRNA in CRC cells, and expression of its gene targets (IRAK1, FUT1, and GPRIN2) was significantly predictive of 5-year overall survival in CRC patients [17].